Skip to main content
972 search results for:

Repaglinide 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 07-02-2024 | Repaglinide | Online First

    Repaglinide restrains HCC development and progression by targeting FOXO3/lumican/p53 axis

    Liver cancer ranks as the third leading cause of new deaths worldwide in all malignancies [ 1 ]. Hepatocellular carcinoma (HCC) comprises over three quarters of cases of liver cancer, and its early intrahepatic metastasis and frequent postoperative …

  2. Open Access 01-12-2021 | Glibenclamide | OriginalPaper

    Meglitinide (repaglinide) therapy in permanent neonatal diabetes mellitus: two case reports

    Diabetes is generally divided into different categories, including type 1 diabetes mellitus (DM), which is caused by autoimmune-mediated beta cell destruction; diabetes related to pancreatic injury; and type 2 diabetes mellitus, with insulin …

  3. 01-06-2020 | Colchicine | OriginalPaper

    Sustained hypoglycemia with therapeutic use of repaglinide

  4. 01-11-2020 | Insulin Glargine | OriginalPaper

    A time to revisit the two oldest prandial anti-diabetes agents: acarbose and repaglinide

    Epidemiological studies have shown that postprandial hyperglycemia considerably contributes to elevated HbA1C levels and is linked to the pathogenesis of chronic diabetes complications particularly cardiovascular issues [ 1 – 7 ]. Of all …

  5. 01-10-2019 | Repaglinide | News

    Repaglinide

    Various toxicities: 4 case reports
  6. 01-08-2019 | Sitagliptin | News

    Repaglinide/valsartan interaction

    Hypoglycaemic episodes: case report
  7. 01-10-2020 | Insulins | OriginalPaper

    Severe hypoglycemia caused by a small dose of repaglinide and concurrent use of nilotinib and febuxostat in a patient with type 2 diabetes

    Repaglinide, an oral hypoglycemic agent, is a short-acting insulin secretagogue. We describe a case, in which an extremely low dose of repaglinide caused severe hypoglycemia and novel drug interactions are suggested. A 71-year-old man with type 2 …

  8. 01-10-2020 | Febuxostat | Erratum

    Correction to: Severe hypoglycemia caused by a small dose of repaglinide and concurrent use of nilotinib and febuxostat in a patient with type 2 diabetes

    In the original publication, the unit of C-peptide immunoreactivity.

  9. 01-09-2021 | Probiotics | News

    Repaglinide/zinc

    Elevation in methanol level and rebound effect in the of elevation in methanol level: case report
  10. 01-07-2020 | Glimepiride | OriginalPaper

    Efficacy and safety of a combination of an insulin secretagogue and a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes mellitus; the repaglinide glucose oscillation study in Fukuoka (REGO-F)

    Insulin deficiency is a critical feature of the pathogenesis of type 2 diabetes mellitus (T2DM). Interestingly, Japanese patients with T2DM demonstrate a greater reduction in insulin secretion secondary to glucose intolerance during the …

  11. 01-10-2019 | Sulfonylurea | News

    Repaglinide

    Hypoglycaemic event: case report
  12. 01-10-2018 | News

    Repaglinide

    Drug induced liver injury: case report
  13. Open Access 01-12-2019 | Itraconazole | OriginalPaper

    Physiologically Based Pharmacokinetic Models for Prediction of Complex CYP2C8 and OATP1B1 (SLCO1B1) Drug–Drug–Gene Interactions: A Modeling Network of Gemfibrozil, Repaglinide, Pioglitazone, Rifampicin, Clarithromycin and Itraconazole

    From epidemiological data, it is estimated that 5–20% of adverse drug events resulting in hospital admission are caused by drug–drug interactions (DDIs), with an especially high risk for elderly patients due to polypharmacy [ 1 ]. Indeed, data show …

  14. 01-02-2016 | News

    Repaglinide overdose

    Prolonged hypoglycaemia and abdominal pain: case report
  15. 01-09-2015 | News

    Repaglinide

    Hypoglycaemia: 3 case reports
  16. 01-09-2008 | OriginalPaper

    Fixed-Dose Combination Tablet of Repaglinide and Metformin is Bioequivalent to Concomitantly Administered Individual Tablets of Repaglinide and Metformin

    Randomized, Single-Blind, Three-Period Crossover Study in Healthy Subjects

    Background and objective: Repaglinide and metformin enhance insulin secretion and decrease hepatic gluconeogenesis, respectively, and are commonly coadministered as separate formulations to treat patients with type 2 diabetes mellitus. A single …

  17. 01-11-2023 | Glibenclamide | News

    Glibenclamide/metformin/repaglinide

    Hypoglycaemia: 2 case reports
  18. 01-01-2012 | OriginalPaper

    Repaglinide

    A Review of Its Use in Type 2 Diabetes Mellitus

    Oral repaglinide (GlucoNorm®; NovoNorm®; Prandin®; Surepost®) is a rapid-acting insulin secretagogue that lowers postprandial glucose (PPG) excursions by targeting early-phase insulin release, with reductions in PPG considered to be important in …

  19. 01-09-2001 | OriginalPaper

    Repaglinide

    A Review of its Therapeutic Use in Type 2 Diabetes Mellitus

    Diabetes mellitus is one of the most common endocrine disorders in the world. In the US alone, there are estimated to be about 16 million adults with this disorder, about one-third of whom remain undiagnosed.[ 1 , 2 ] Type 2 diabetes mellitus …

  20. 01-04-2004 | ReviewPaper

    Repaglinide

    A Pharmacoeconomic Review of its Use in Type 2 Diabetes Mellitus

    Repaglinide (Prandin®, NovoNorm®, GlucoNorm®) The use of trade names is for product identification purposes only and does not imply endorsement. , was the first meglitinide analogue[ 1 ] to become available for the treatment of patients with type 2 …

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.